Skip to main content
Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
11.04
+0.04 (0.36%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Roivant Sciences Revenue

Roivant Sciences had revenue of $9.02M in the quarter ending December 31, 2024, a decrease of -42.05%. This brings the company's revenue in the last twelve months to $122.59M, up 140.04% year-over-year. In the fiscal year ending March 31, 2024, Roivant Sciences had annual revenue of $124.80M with 103.65% growth.

Revenue (ttm)
$122.59M
Revenue Growth
+140.04%
P/S Ratio
67.29
Revenue / Employee
$135,006
Employees
908
Market Cap
7.86B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024124.80M63.52M103.65%
Mar 31, 202361.28M5.99M10.84%
Mar 31, 202255.29M31.49M132.34%
Mar 31, 202123.80M-43.89M-64.85%
Mar 31, 202067.69M65.37M2,812.61%
Mar 31, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.90B
Revenue Rankings

ROIV News

More News